InvestorsHub Logo
Followers 12
Posts 588
Boards Moderated 0
Alias Born 10/18/2010

Re: janetjackson post# 420

Monday, 03/19/2012 8:14:42 PM

Monday, March 19, 2012 8:14:42 PM

Post# of 13168
Webinar was very interesting. They were very careful, as expected, about announcing any agreements with healthcare companies, insurance groups or govt. agencies. Of note, what they didn't say might have been a key..regarding questions about Medicare and Medicaid. I'm pumped from what I heard. Also, the slide and discussion about "possible" cash flow was heavy duty info. Said pre-tax cash flow of approx. $4.50 per share is potential from just the insulin dependent diabetics. This is a WOW factor. $4.50 cash flow should equate to a share price range of $90.00 to $120.00 a share. Of course, WHEN is the issue. But also consider this is only with insulin dependent diabetics.......does not include all the other 15 million plus diabetics, nor the other chroinic diseases which they said they would go after. A question about the ALRT HeC system becoming the WINDOWS of healthcare was brought out. I'm more positive than ever on the future.